Assistance Listing 93.395
Department of Health and Human Services · National Institutes of Health
Assistance Listing 93.395, “Cancer Treatment Research,” is a federal program administered by Department of Health and Human Services. It provides cooperative agreement and grant assistance. GrantsJunction currently tracks 36 open, 13 forecasted and 5 closed opportunities under this listing. The agency reported $1.41B in obligations for fiscal year 2025.
To develop the means to cure as many cancer patients as possible and to control the disease in those patients who are not cured. Cancer Treatment Research includes the development and evaluation of improved methods of cancer treatment through the support and performance of both fundamental and applied laboratory and clinical research. Research is supported in the discovery, development, and clinical testing of all modes of therapy including: surgery, radiotherapy, chemotherapy, and biological therapy including molecularly targeted therapies, both individually and in combination. In addition, research is carried out in areas of nutritional support, stem cell and bone marrow transplantation, image guided therapies and studies to reduce toxicity of cytotoxic therapies, and other methods of supportive care that may supplement and enhance primary treatment. Small Business Innovation Research (SBIR) program: To expand and improve the SBIR program; to increase private sector commercialization of innovations derived from Federal research and development; to increase small business participation in Federal research and development; and to foster and encourage participation of socially and economically disadvantaged small business concerns and women-owned small business concerns in technological innovation. Small Business Technology Transfer (STTR) program: To stimulate and foster scientific and technological innovation through cooperative research and development carried out between small business concerns and research institutions; to foster technology transfer between small business concerns and research institutions; to increase private sector commercialization of innovations derived from Federal research and development; and to foster and encourage participation of socially and economically disadvantaged small business concerns and women-owned small business concerns in technological innovation.
As published in the SAM.gov Assistance Listing.
The awardee will be a university, college, hospital, public agency, nonprofit research institution, or for-profit organization that submits an application and receives a grant or cooperative agreement for support of research by a named principal investigator. SBIR grants can be awarded only to domestic small businesses (entities that are independently owned, and operated for profit, are not dominant in the field in which research is proposed and have no more than 500 employees). Primary employment (more than one-half time) of the principal investigator must be with the small business at the time of award and during the conduct of the proposed project. In both Phase I and Phase II, the research must be performed in the U.S. and its possessions. To be eligible for funding, a grant application must be approved for scientific merit and program relevance by a scientific review group and a national advisory council. STTR grants can be awarded only to domestic small business concerns (entities that are independently owned and operated for profit, are not dominant in the field in which research is proposed and have no more than 500 employees) which "partner" with a research institution in cooperative research and development. At least 40 percent of the project is to be performed by the small business concern and at least 30 percent by the research institution. In both Phase I and Phase II, the research must be performed in the U.S. and its possessions. To be eligible for funding, a grant application must be approved for scientific merit and program relevance by a scientific review group and a national advisory council.
Intended beneficiaries: Individual/Family, Private nonprofit institution/organization and Public nonprofit institution/organization.
Program-level eligibility from SAM.gov. Each funding notice sets its own requirements.
Range and average of financial assistance (from the listing): Range: $5,000 to $22,055,360 Average: $653,665
Source: SAM.gov Assistance Listing 93.395. Hatched bars are agency estimates. These totals do not indicate approval rates.| Opportunity | Status | Award range | Closes | ALN |
|---|---|---|---|---|
| Closed | Amount not specified | Sep 25, 2026 | 93.121, 93.395 | |
NCI Community Oncology Research Program (NCORP) Academic Community Sites (UG1 Clinical Trials Not Allowed)National Institutes of Health | Closed | Amount not specified | Sep 18, 2026 | 93.393, 93.395, 93.399 |
NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Not Allowed)National Institutes of Health | Closed | Amount not specified | Sep 18, 2026 | 93.393, 93.395, 93.399 |
| Closed | Up to $499K | Sep 7, 2026 | 93.393, 93.394, 93.395, 93.396 | |
| Closed | Amount not specified | Sep 7, 2026 | 93.395 |
93.395 is the Assistance Listing Number for “Cancer Treatment Research.” Assistance Listing Numbers (formerly CFDA numbers) identify federal assistance programs; individual grant opportunities reference the listing they are funded under.
The SAM.gov listing names these applicant types: For-Profit Organization, Small Business Person, Not-for-Profit Organization, Nonprofit Organization, Local, State, Territorial, International Organization and Tribal. Each funding notice under the program sets its own eligibility, so check the specific opportunity.
The agency reported $1,414,965,434 in obligations for FY2025 in the SAM.gov Assistance Listing. These are program-wide totals reported by the agency, not a prediction of future awards.